Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson's (2020)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2020.07.03.186411

Publication URI: http://dx.doi.org/10.1101/2020.07.03.186411

Type: Preprint